Delivery Order SPE2DB22D3501-SPE2DB25FXE60
- Not listed
- The Defense Logistics Agency awarded a $1,434.58 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Meropenem 0.9% Sodium Chloride 1 Gram/50 units. This competitively awarded, firm fixed-price contract is set to be completed by August 11, 2025, with performance taking place at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a child delivery order issued under a larger vehicle, consistent with AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $14,618.80 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Meropenem 0.9% Sodium Chloride 1 gram/50 milliliters. This contract represents a competitively awarded, non-set-aside delivery order with firm fixed pricing under an Indefinite Delivery Contract vehicle. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 15,...
- The Defense Logistics Agency awarded a delivery order valued at $7,365.36 to AmerisourceBergen Drug Corp for the supply of Meropenem 0.9% Sodium Chloride 1 Gram/50s, a broad-spectrum antibiotic used in military and federal healthcare settings. The award, issued on August 14, 2025, with completion targeted for August 15, 2025, utilizes firm fixed pricing under a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performance...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,668.21 on June 16, 2025, for the supply of Meropenem 0.9% Sodium Chloride 1 gram/50 units. This firm fixed price contract, which was not set-aside, is set for completion by June 17, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of pharmaceutical support services through the company's existing contract vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $1,317.62 to AmerisourceBergen Drug Corp for the supply of Meropenem 2 gram vials, an antibiotic pharmaceutical product. The contract was awarded on August 21, 2025, with an ultimate completion date of August 22, 2025, using firm fixed price terms without any set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,172.48 to AmerisourceBergen Drug Corp for the supply of Meropenem 2 gram vials, with an ultimate completion date of September 5, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its pharmaceutical distribution operations...
- This delivery order, valued at $3,055.46, was awarded to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Meropenem 0.9% Sodium Chloride (1 gram/50 milliliters) to support federal medical procurement needs. The contract employs firm fixed pricing and carries an ultimate completion date of August 15, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for the federal government's military and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $14,980.44 firm fixed-price delivery order is for 4,565,422,154 units of the antibiotic drug Meropenem-0.9% Sodium Chloride 1 gram/50s. This delivery order falls under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the provision of 4,563,697,433 units of the pharmaceutical drug meropenem, a 2 gram vial. The contract has a total potential value of $2,440.78 and a completion date of February 20, 2024. This delivery order contract is not...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,269.70 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, for the supply of Ertapenem 1 gram vials. This competitively awarded, firm fixed-price contract has an ultimate completion date of July 22, 2025, and represents a small-value pharmaceutical procurement with no set-aside designation. The award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXE60Delivery Order
The Defense Logistics Agency awarded a $8,127.12 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Meropenem 0.9% sodium chloride (1 gram/50 mL) pharmaceutical product. This is a firm fixed-price delivery order with an ultimate completion date of September 8, 2025, and represents a non-competitive award. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical supply vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is well-positioned to fulfill federal medical procurement needs through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. The company's federal contract awards demonstrate consistent capability in delivering pharmaceutical products across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for Meropenem, an antibiotic product, aligns with the company's established role as a critical vendor for military and veteran healthcare procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.1k | 9/5/25 |